These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12880379)

  • 21. [Application of adeno-associated virus-mediated gene therapy in lysosomal storage diseases].
    Lin XQ; Wang XL; Peng J
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Nov; 24(11):1281-1287. PubMed ID: 36398557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent developments in therapeutic approaches for lysosomal storage diseases.
    Urbanelli L; Magini A; Polchi A; Polidoro M; Emiliani C
    Recent Pat CNS Drug Discov; 2011 Jan; 6(1):1-19. PubMed ID: 21073432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy for lysosomal storage disorders.
    Yew NS; Cheng SH
    Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():99-109. PubMed ID: 24380128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem Cell Applications in Lysosomal Storage Disorders: Progress and Ongoing Challenges.
    Köse S; Aerts-Kaya F; Uçkan Çetinkaya D; Korkusuz P
    Adv Exp Med Biol; 2021; 1347():135-162. PubMed ID: 33977438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on treatment of lysosomal storage diseases.
    Bruni S; Loschi L; Incerti C; Gabrielli O; Coppa GV
    Acta Myol; 2007 Jul; 26(1):87-92. PubMed ID: 17915580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene therapy progress and prospects: gene therapy of lysosomal storage disorders.
    Cheng SH; Smith AE
    Gene Ther; 2003 Aug; 10(16):1275-81. PubMed ID: 12883523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging therapies for neuropathic lysosomal storage disorders.
    Kelly JM; Bradbury A; Martin DR; Byrne ME
    Prog Neurobiol; 2017 May; 152():166-180. PubMed ID: 27725193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers for gene therapy clinical trials of lysosomal storage disorders.
    Rossi A; Malvagia S; la Marca G; Parenti G; Brunetti-Pierri N
    Mol Ther; 2024 Sep; 32(9):2930-2938. PubMed ID: 38850023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in therapies for neurological lysosomal storage disorders.
    Ellison S; Parker H; Bigger B
    J Inherit Metab Dis; 2023 Sep; 46(5):874-905. PubMed ID: 37078180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of lysosomal storage diseases: recent patents and future strategies.
    Ortolano S; Viéitez I; Navarro C; Spuch C
    Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):9-25. PubMed ID: 24433521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy for lysosomal storage diseases and peroxisomal diseases.
    Ohashi T
    J Hum Genet; 2019 Feb; 64(2):139-143. PubMed ID: 30498239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene therapy for lysosomal storage disorders with neuropathology.
    Ioannou YA
    J Am Soc Nephrol; 2000 Aug; 11(8):1542-1547. PubMed ID: 10906169
    [No Abstract]   [Full Text] [Related]  

  • 33. Current strategies in the management of lysosomal storage diseases.
    Heese BA
    Semin Pediatr Neurol; 2008 Sep; 15(3):119-26. PubMed ID: 18708002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy for lysosomal storage disorders.
    Gritti A
    Expert Opin Biol Ther; 2011 Sep; 11(9):1153-67. PubMed ID: 21548845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene therapy approaches for lysosomal storage disorders, a good model for the treatment of mendelian diseases.
    Tomanin R; Zanetti A; Zaccariotto E; D'Avanzo F; Bellettato CM; Scarpa M
    Acta Paediatr; 2012 Jul; 101(7):692-701. PubMed ID: 22428546
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Poletto E; Silva AO; Weinlich R; Martin PKM; Torres DC; Giugliani R; Baldo G
    Expert Opin Biol Ther; 2023 Apr; 23(4):353-364. PubMed ID: 36920351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatments for lysosomal storage disorders.
    Lachmann R
    Biochem Soc Trans; 2010 Dec; 38(6):1465-8. PubMed ID: 21118108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier.
    Critchley BJ; Gaspar HB; Benedetti S
    Mol Ther; 2023 Mar; 31(3):657-675. PubMed ID: 36457248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Journey towards Understanding the Molecular Pathology and Developing Therapies for Lysosomal Storage Disorders.
    Tikkanen R
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene therapy for the central nervous system in the lysosomal storage disorders.
    Kaye EM; Sena-Esteves M
    Neurol Clin; 2002 Aug; 20(3):879-901. PubMed ID: 12432834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.